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ABSTRACT
Excessive ethanol consumption may increase the production of reactive oxygen species (ROS), which results in the oxidative
damage of tissues. The purpose of this study was to evaluate the effects of melatonin on the antioxidative status in the PC12 cell
line after exposure to ethanol. In this study, the PC12 cells were treated with the different concentrations of melatonin for 24 hr.
Subsequently, the cells were incubated with a fresh medium containing 150 mM of ethanol for 4 hr. To observe the oxidative damage
and evaluate the antioxidative status after acute exposure to ethanol, cell viability, percentage of lactate dehydrogenase released (%
LDH released), glutathione (GSH) level, activities of superoxide dismutase (SOD) and glutathione reductase (GRx), and concentrations of the protein carbonyls were assayed. The results showed that cell viability and GSH were increased, whereas the ethanolinduced cytotoxicity and protein carbonyl concentration decreased when the PC12 cells were treated with 10, 100 and 1000 µM
melatonin. In contrary, there was no significant difference in the activity of SOD in the ethanol-treated group. In addition, there were
no significant differences in the activity of GRx in the groups with the treatment of 10 and 100 µM melatonin; however, GRx activity
decreased in the cells treated with 1000 µM melatonin. In conclusion, melatonin of moderate concentration may be a protective agent
to alleviate acute ethanol-induced oxidative damage by the generation of GSH in the PC12 cell line.
Key words: PC12 cell line, ethanol, melatonin, glutathione, protein carbonyl

INTRODUCTION
Excessive and prolonged ingestion of ethanol could
result in the damage of human tissues, including liver (1),
brain (2), nervous system (3), and digestive system (4). In
addition to the direct damages of ethanol, the ethanol-induced
damage is related to its metabolic products(5,6). ROS can
cause damage to all types of biomolecules, including DNA,
proteins, and lipids (lipid peroxidation). The carbonyl assay
which is based on the fact that several ROS attack aminoacid residues in proteins to produce products with carbonyl
groups is a general assay of oxidative protein damage. An
elevation of the carbonyl compounds that are biomarkers
of and leading to oxidative stress has been demonstrated in
Down Syndrome (DS), Alzheimer’s Disease (AD) brains,
neurodegenerative diseases and aging(7-9).
It is well known that the intake of excess ethanol
is toxic to human body; therefore, how to enhance the
antioxidative capability for alcoholics is an interesting topic
for us. Glutathione (GSH), a tripeptide product synthesized
* Author for correspondence. Tel: +886-7-3121101 ext. 7262;
Fax: +886-7-2370544; E-mail: tsailiyu2005@yahoo.com.tw

from cysteine, glutamate, and glycine, is a low-molecularweight thiol reductant present in most cells. It is also well
known that intracellular antioxidant GSH plays major
roles in the maintenance of the redox status and defense
of oxidative stress because it participates directly in the
destruction of reactive oxygen species (10) . Numerous
experimental studies have shown that the activity of
antioxidant enzymes, for example SOD and GRx, exhibited
various expressions with different conditions of oxidative
stress(11-14). A lot of research indicated that ethanol-induced
damage could be reduced with appropriate antioxidants. It
has been observed that certain hormone also has antioxidant
ability. For example, melatonin, the primary hormone of
the pineal gland, is both a potent free radical scavenger
and a broad spectum antioxidant(15,16), in addition to its
other well-known physiological functions. It has been
speculated that primary function of melatonin may include
protecting organisms from intrinsically or environmentally
induced oxidative stress. Oner-Iyidogan et al.(17) indicated
that melatonin might act as a protective agent against
the testicular injury caused by ethanol consumption by
enhancing the activity of antioxidative enzymes. In the
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study of El-Sokkary et al. (18), melatonin was shown to
possess the ability to inhibit lipid peroxidation caused by
chronic ingestion of ethanol. Roth et al.(19) indicated that
the distinct expression from different concentrations of
melatonin appeared in the growth or death of the PC12 cells.
To observe the direct effect of ethanol on neuron
cells, the neuron-like cell line or the cell more sensitive
to ethanol is usually used as a neuron cell model to study
ethanol-induced stress. In the studies by Pantazis et al.(20)
and Sun et al.(21), the PC12 cells were regarded as a model
for examining the effect of ethanol on iron-induced lipid
peroxidation and cell death. Therefore, the PC12 cell line is
a useful model system for ethanol-induced neurobiological
and neurochemical studies. The effects of ethanol-induced
damage due to chronic ingestion were more focused than
those of acute and high dosage(22). In the study by Pantazis
et al. (20) , the proliferation of the PC12 cell lines was
inhibited by the treatment with 100, 200, 400 and 800 mg/dL
of ethanol after four days. In the study by Li et al.(23), the
reduction of the PC12 cell lines was more than 75% when
the cells had been treated with ethanol at a concentration
higher than 100 mM after 24 hr. The common denominator
of all the studies mentioned above is that the period of
treatment was longer than 24 hr. The objective of this study
was to evaluate the effect of high concentration of melatonin
on the antioxidative status in the PC12 cell line after acute
exposure to ethanol.

MATERIALS AND METHODS

III. Designed Concentration of Melatonin
Melatonin levels in blood are low during the day
(about 0.04 µM) and gradually elevated at 6 p.m. Melatonin
levels peak (about 0.5 µM) at about 2 a.m. in healthy young
people and at about 3 a.m. in elderly people. At sunset,
the cessation of light triggers neural signals that stimulate
the pineal gland to begin releasing melatonin. This rise
continues for hours, eventually peaks around 2 a.m. after
which it steadily declines to the minimal levels by morning.
Both the delay in timing and the decrease in intensity of the
melatonin pulse are manifestations of the aging process(24).
There were documented studies indicating that Roth et
al.(19) showed the melatonin at lower concentrations (1~10
nM) suppressed the growth of the PC12 cells whereas at
higher concentration (10 µM) prevented cell death; Song
and Lahiri(25) indicated that the production of beta-amyloid
precursor protein in the PC12 cells could be inhibited by the
higher concentration (3~4 mM) of melatonin. In addition, in
the study of Bao et al.(26), they indicated that the 1-methyl4-phenylpyridinium-induced death in the PC12 cells could
be suppressed by 250 µM of melatonin. Therefore, higher
concentration of melatonin was used in order to evaluate
whether melatonin could promote the antioxidant ability
on the PC12 cells. Ten, 100 and 1000 µM melatonin were
selected for this study. Nevertheless, the above-mentioned
higher concentration of melatonin could be treated only
in the in vitro studies. The concentrations of melatonin of
normal physiological situation have to be considered if the
experiments are carried out in vivo.

I. Materials

IV. Treatment of Cell Lines

The ethanol medium was made up of absolute ethanol
(Sigma, Chemical Co., St. Louis, MO, USA) dissolved in
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco,
Grand Island, NY, USA). The 1×105 µM of melatonin (M.W.
232.2 g, Sigma, USA) was made up of 23.2 mg melatonin
dissolved in 1.0 mL of dimethylsulfoxide (DMSO) (Gibco,
USA) and then diluted to 10, 100 and 1000 µM melatonin
by fresh DMEM.

On the first day, 1.5 mL of cell suspension (about 1×106
cell/mL) from cell culture flasks was transferred to culture
plates of 6 wells in order to adhere to the wall of the culture
plate in the control and experimental group, respectively.
On the second day, we removed the medium from the
culture plate and then added the medium with the equivalent
volume of different concentrations of melatonin to the
culture plate in both the control and experimental group.
On the third day, the medium of melatonin was removed
after 24 hr of incubation and the cells were washed with
PBS twice to avoid the remains of melatonin in the culture
plate. Subsequently, the cells were incubated for 4 hr with
a fresh medium containing 150 mM ethanol in the control
groups and experimental groups, respectively. To reduce
the interference of the vaporation of ethanol, we sealed the
culture plate with a parafilm and punctured three small holes
with a syringe.

II. Cell Culture
The PC12 cell line (American Type Culture Collection,
CRL-1721, USA) derived from a transplantable rat
pheochromocytoma was used for this study because of its
documented sensitivity to ethanol-toxicity and neuronlike characteristic. The cells were grown routinely in T75
plastic tissue culture flasks in DMEM containing 10%
heat-inactivated fetal bovine serum (FBS, Biological Ind.
Haemek, Israel), 100 µg/mL of streptomycin sulfate, 0.25
µg/mL of amphotericin, 100 units/mL of penicillin, 1
mM of non-essential amino acid and 100 U/mL of insulin
(Biological Ind., Haemek, Israel) and incubated in 85%
humidified air and 5% CO2 at 37°C.

V. Assay of Cell Viability
Cell viability was assessed by trypan blue dye
exclusion. In all experiments, the medium was gently
removed from the well after 4 hr of ethanol exposure. The
number of cells was counted by using a light microscope
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on a hemocytometer slide. The cell numbers per well were
determined by counting the cells of a given well three times,
and the mean was calculated. Cell viability was expressed
as the percentage of the cell number according to the
following formula: Cell viability (%) = (cell numbers in the
groups treated with melatonin at different concentrations ÷
cell numbers in the group without melatonin treatment) ×
100.
VI. Assay of Cytotoxicity
Cytotoxicity was estimated by measuring the activity
of the released LDH. After the PC12 cells were incubated
with agents for 4 hr as shown above, the medium, which
contained few detached cells, was centrifuged at 50 ×g for
5 min. The supernatant was used for the assay of the LDH
activity on an autoanalyzer (model: Vitros 750, Johnson &
Johnson). Total LDH in cells was determined after lysing
cells with 0.1% triton X-100 in DMEM. Cytotoxicity was
expressed as the percentage of the LDH released according
to the following formula: % LDH released = [(LDH in
medium) ÷ (LDH in medium + LDH in survival cells)] ×
100(27).
VII. Assay of GSH
The 100 µL of cell suspension in an amber
microcentrifuge tube was mixed with 0.1% MPA by the
1:2 volumetric ratio, and then it was centrifuged at 500 ×
g for 10 min after being adequately mixed by a vortex
mixer. The supernatant was assayed on the capillary
electrophoresis analyzer (P/ACE MDQ, Beckman Coulter)
after being filtered with a 0.2 µm syringe set. The analysis
was performed at a constant temperature (28°C) with 300
mM borate running buffer (pH 7.8) equipped with a UV
absorbance detector set to 200 nm(28).
VIII. Assay of SOD and GRx Activity
Cells from the wells for viability assessment were
mixed homogenously and were centrifuged at 50 ×g for
5 min. After the supernatant was removed, the cell pellet
was remixed with 200 µL of PBS and then 100 µL of cell
suspension was assayed for the activity of SOD, GRx and
protein analysis, and another 100 µL for the measurement of
GSH. One hundred microliter of cell suspension was mixed
with 0.1% triton X-100 in the 1:2 volumetric ratio, and then
centrifuged at 500 ×g for 10 min after being adequately
mixed by a vortex mixer. The supernatant was assayed for
the activity of SOD and GRx on Synchron CX 5 (Beckman
Coulter). The activities of SOD and GRx were assayed with
commercial assay kits (Randox Laboratory Ltd. Antrim,
UK).
IX. Assay of Protein Carbonyl
The protein carbonyl content was measured according

to the method described by Levine et al. (29) . Protein
carbonyl derivatives readily reacted with 2,4-dinitropheny
lhydrazine (2,4-DNPH) to form hydrazone derivatives that
could be measured spectrophotometrically. The 150 µL
supernatant of assaying SOD and GRx was reacted with 600
µL of 10 mM DNPH (in 2.5 M HCl) for 1 hr with occasional
mixing, and TCA precipitates were washed three times with
1 mL of ethanol/ethyl acetate (1:1). Pellets were broken up
mechanically. The final pellet was dissolved in 1 mL of 6
M guanidine hydrochloride and 0.5 M potassium phosphate,
pH 2.5, and A370 were measured. A blank with the protein
reacted with 2 M HCl containing no DNPH was carried
for each sample and its absorbance was subtracted. The
carbonyl content was determined as nmol/mg protein using
ε370 = 22000 M-1 cm-1.
X. Statistical Analysis
Statistical results were analyzed with one-way ANOVA
to assess the significance of differences between groups.
Data were expressed as mean ± standard deviation (S.D.),
statistically significant at p < 0.05. Each test was carried out
in triplicate.

RESULTS AND DISCUSSION
I. Assessment of the Cell Viability after Melatonin Treatment
To establish LC50 as an in vitro model for evaluation,
viability of the cells and ethanol-induced cytotoxicity were
assayed by the treatment with 45, 95, 140, 220, 380, 460
mM of ethanol after 2, 4, 8 hr in culture plates with 96, 48,
6 wells, respectively. In this study, the viability of cells
was 52.5% in 140 mM of the ethanol group, approximately
matching our request for LC50 after ethanol treatment for
4 hr. As the result, we adopted the 150 mM of ethanol as
LC50. In Randall and Peter’s study(30), human astroglia
cells were utilized to examine the expression of inducible
nitric-oxide synthase after the acute exposure to 50 and 200
mM ethanol. Although the concentration of ethanol was far
above physiological levels, we still adopted it in order to
establish a uniform condition for the evaluation model in the
consequent experiments.
In this work we investigated the effect of melatonin on
cellular viability of the PC12 cells. The results showed that
exposure of the PC12 cells to ethanol induces a reduction
on cell viability shown as Figure 1(A). As shown in Figure
1(A), there was not significant difference (p > 0.05) on the
viability of cells in groups without ethanol treatment even
though the concentrations of melatonin had been increased.
But in the groups with ethanol treatment, the viability of
cells with added melatonin increase more than the groups
without added melatonin, especially the groups treated
with 100 and 1000 µM of melatonin (p < 0.01). However,
in the groups with higher concentrations of melatonin, the
viability of cells showed no significant difference in the
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III. Assessment of GSH
To evaluate the role of GSH in ethanol toxicity
after treatment of melatonin, the PC12 cells were treated
with different concentrations of melatonin for 24 hr. We
found that the concentrations of GSH increased only after
treatment with 100 and 1000 µM melatonin in the groups
without ethanol treatment (p < 0.05 and p < 0.01). However,
there were all significant increases (p < 0.01) after treatment
with melatonin in groups with ethanol treatment shown as
Figure 2(A). Kilanczyk and Bryszewska(32) have reported
that exposure to 100~1000 µM of melatonin could cause a
significant increase in the GSH level in human diabetic skin
fibroblasts. GSH plays an important role in the protection
of cells against ethanol toxicity. It had been demonstrated
that an intracellular GSH level decreases after ethanol
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II. Assessment of Cytotoxicity
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LDH released (%)

The ethanol-induced toxicity was evaluated by
determining the % LDH released upon incubation of the
PC12 cells for 4 hr with 150 mM ethanol. As shown in
Figure 1(B), the % LDH released of the ethanol-treated
groups was apparently greater than the groups without
ethanol treatment. But in the ethanol-treated groups, the %
LDH released showed significant decrease (p < 0.01) after
treatment of melatonin, especially in the 100 µM melatonin
group. The % LDH released in 10 and 100 µM of the
melatonin-treated groups showed no significance (p > 0.05)
between the groups with ethanol or without ethanol. From
the aforementioned results, the pretreatment of melatonin
could prevent cells from the damages of acute ethanolinduced free radicals; the phenomenon might attribute
to the neutralization of free radicals by melatonin on cell
membranes, and this result was similar to the document
by Garcia et al. (31) which stated moderate treatment of
melatonin could destroy the free radicals on cell membranes
to maintain fluidity of the membrane. Meanwhile, the
results also showed that the treatment of excessively high
concentrations of melatonin might elevate cytotoxicity, as
shown in Figure 1(B). For the results mentioned above,
although the addition of melatonin to cells could reduce
the ethanol-induced toxicity, the appropriate concentration
of melatonin has to be considered if it is to be adopted for
clinical application.

10

**
Cell viability (%)

ethanol-treated groups compared with the groups without
ethanol treatment. This study provides further evidence
for the toxicity of ethanol in the PC12 cell line. With the
cell models, we demonstrated that melatonin significantly
increase cell viability and reduce the damage in the cells
exposed to ethanol. In addition, although a significant
increase after the addition of melatonin in cell viability was
observed in the PC 12 cells, we also had to consider the
physiological concentrations of melatonin to examine if
higher concentrations of melatonin were applied to animal
models.

8.0
6.0
4.0
**

2.0
1.5

1.3

1.0

N

1.1

Ethanol

**

1.5

1.2

**
1.7
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Figure 1. Change of cell viability (A), % LDH released (B) in the
PC12 cell line after exposure to 150 mM of ethanol for 4 hr in
the culture plate with 6 wells. N: non-treatment with ethanol, Y:
treatment with ethanol. Data represent the mean ± S.D. of at least
three experiments, each conducted in triplicate (#p < 0.05, compared
to groups without the addition of melatonin in the groups without
ethanol; **p < 0.01, compared to groups without the addition of
melatonin in the groups with ethanol).

treatment, since the ROS produced by ethanol metabolism
can bind to the SH group and decrease the GSH level(33). In
this study, we found that the level of GSH was remarkably
decreased after acute exposure to ethanol. However, the
treatment of melatonin could enhance the production of
GSH in both groups, especially in the ethanol-treated groups
but the mechanism of enhancing the production of GSH
was unknown. At first, we attempted to assay the GSH and
GSSG levels to evaluate whether melatonin could promote
the production of GSH in the PC12 cells after the treatment
of melatonin. We measured the GSH and GSSG levels in
cell suspension samples by the capillary electrophoresis
analyzer but the level of GSSG could not be obtained
because it was either undetectable or too low. So we did not
display the ratio of GSH/GSSG to evaluate the antioxidant
capacity in the PC12 cells after the treatment of melatonin.
Furthermore, it has been reported that the ratio of GSH/
GSSG in the culture cells after the exposure of ethanol (about
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Figure 3. Change of protein carbonyl in the PC12 cell line after
exposure to 150 mM of ethanol for 4 hr in the culture plate with 6
wells. N: non-treatment with ethanol, Y: treatment with ethanol.
Data represent the mean ± S.D. of at least three experiments, each
conducted in triplicate (#p < 0.05, compared to groups without the
addition of melatonin in the groups without ethanol; *p < 0.05 and
**p < 0.01 respectively, compared to groups without the addition of
melatonin in groups with ethanol).
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93~144:1) was higher than that in the blood (about 10:1)(34),
which indicates that the level of GSSG in culture cells might
be very low so that the ratio of GSH/GSSG was higher.
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Figure 2. Change of GSH (A), GRx (B), SOD (C), in the PC12
cell line after exposure to 150 mM of ethanol for 4 hr in the culture
plate with 6 wells. N: non-treatment with ethanol, Y: treatment with
ethanol. Data represent the mean ± S.D. of at least three experiments,
each conducted in triplicate (#p < 0.05 and # #p < 0.01 respectively,
compared to groups without the addition of melatonin in the groups
without ethanol; **p < 0.01, compared to groups without the addition
of melatonin in the groups with ethanol).

IV. Assessment of the Activities of GRx and SOD
The GSH for enhancing the defense system in cells
could be produced by reducing the GSSG (an oxidized form
of GSH) to GSH through the action of GRx. To evaluate
the role of GRx in toxicity, the activity of GRx was assayed
and the results are showed in Figure 2(B). After treatment
with the different concentrations of melatonin, no significant
change appeared in the activity of GRx in the groups
without ethanol treatment. When the cells were treated with
lower than 1000 µM (10 and 100 µM) melatonin in the
groups with ethanol treatment, there were also no significant
changes in the activity of GRx. However, the concentration
of melatonin up to 1000 µM had a significantly lower effect
(p < 0.01) on the activity of GRx in the groups with ethanol
treatment. The weak activity of GRx after the treatment of
the higher concentration of melatonin might be caused by
the fact that free radicals had been neutralized by melatonin,
and no more GSH was needed through the reduction of
GSSG by GRx to diminish the free radicals. Hence, the
elevated GSH after the treatment of melatonin did not
result from the increased activity of GRx in this study. In
addition, the activity of SOD showed significant increase
after the treatment of ethanol compared with the groups
without ethanol treatment. We suggested that the production
of superoxide after exposure to ethanol must be removed by
SOD. The activity of SOD showed no significant change
after treatment of melatonin in both groups (Figure 2C),
indicating the treatment of melatonin did not stimulate the
activity of SOD in this study.
The activities of the antioxidant enzymes after the
addition of melatonin showed various characteristics.
More studies on how to influence the mechanisms of the
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antioxidant enzymes by melatonin are still required.
V. Assessment of Protein Carbonyls
To evaluate whether melatonin influenced the
ethanol-induced oxidative damage or not, we measured
the malondialdehyde (MDA) and protein carbonyl levels
by the colorimetric method in the PC12 cell. The protein
carbonyl levels exhibited an increased trend after exposure
to the ethanol, but the levels of MDA could not be detected
in this study. The reasons for undetectable levels of MDA
might be attributed to the fact that the period of ethanol
treatment was too short so that the levels of MDA could not
be accumulated for detection by the colorimetric method.
Therefore, we adopted protein carbonyl level as the marker
of oxidative damage after acute ethanol treatment.
Figure 3 shows that when melatonin treatment was
not administered, protein carbonyl concentrations were
higher in the ethanol-treated groups than in the groups
without ethanol. As shown in Figure 3, the concentrations
of protein carbonyl did not show any significant difference
even though different concentrations of melatonin were
added to the groups without ethanol treatment. In groups
with ethanol treatment, however, the concentrations of
protein carbonyl showed significant decreases (p < 0.01 and
p < 0.05) after the treatment of 10 and 1000 µM melatonin.
Protein carbonyl assay was used as an indicator of protein
damage by free radical reactions in vitro and in a variety
of pathologies. In this study, the levels of protein carbonyl
increased significantly after the treatment with ethanol, and
the treatment of moderate melatonin could decrease the
production of protein carbonyl. Protein carbonyl levels did
not decrease after the treatment with the higher concentration
of melatonin, while various concentrations of melatonin
had different effects to oxidize protein in the PC12 cell
lines. Thus, the cytotoxicity of ethanol might be due to the
protein damage (carbonyl formation). Many previously
documented reports indicated that protein damage could
be reduced by melatonin by several mechanisms, including
(1) modification of the neural response to 3-nitropropionic
acid which could induce oxidative stress in some brain
regions(35), (2) reduction of the effectiveness on cells by
alkyl peroxyl radicals(36), and (3) scavenging of oxygen free
radicals and stimulation of antioxidant enzyme activity(37).
In this study, the antioxidant melatonin with a moderate
concentration interacted with the oxidant and protected cells
during ethanol exposure by diminishing ethanol-induced
cytotoxic effects and reducing protein carbonyl generation.
With regard to the mechanisms that melatonin reduced the
ethanol-induced protein damages, we will conduct more
research in the future.

CONCLUSIONS
In summary, we have shown that melatonin increases
intracellular of GSH and decreases cytotoxicity of ethanol

to PC12 cells at high concentration. Furthermore, the
results showed that melatonin, at a moderate concentration,
may serve as a protective agent to alleviate acute ethanolinduced damage in the PC12 cell lines. Hence, we believe
that the application of melatonin against the ethanolinduced oxidative damage needs more in vivo studies to
elucidate how melatonin exerts the cytoprotective effect in
appropriate concentration. We are currently extending our
in vitro studies to investigate the potential mechanism of the
protection of melatonin during acute ethanol treatment in the
PC12 cell line.
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